English
|
Spanish
Login
Register
The content on this site is intended for healthcare professionals only
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[265]
News
[1742]
Articles
[54]
Editorials
[3]
Conferences
[47]
e
learning
[10]
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Bridge therapy may benefit some children with high-risk neuroblastoma
ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric lo...
Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell l...
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
Epilepsy drug stops nervous system tumour growth in mice
Study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level
Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours
Researchers shed light on why a certain plant virus is so powerful at fighting cancer
<
1
2
3
4
5
...
175
>
More from
e
cancer
